glp-1 obesity drugs pipeline Can Novo Nordisk's transform treatment? The Landscape Of GLP-1 Receptor
Description
Oral semaglutide
N Engl J Med 2021;384:1719-30.ArticlePubMed 31
For information about the UTSW Weight Wellness Program, call 214-645-2800 or request an appointment online
The utility of GLP-1 receptor agonists continues to expand as healthcare providers and patients seek holistic treatments for complex metabolic syndromes, strengthening their position in modern therapeutic regimens
